Drobuline

This classification denotes an antiarrhythmic agent with the molecular formula C19H25NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 6LLN8EQ6TA, chemically known as benzenepropanol, alpha-(((1-methylethyl)amino)methyl)-gamma-phenyl-, (+-)- but more generally known as drobuline, which bears US NIH Compound Identifier 60890. European Medicines Agency schedules Drobuline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06401MIG. The term DROBULINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 31, No10, 1977, List 17). DROBULINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule drobuline under HS 29221980 and SITC 51461. As of Q4 2014, DROBULINE remains US FDA's Preferred Term for this commodity. Drobuline bears US NLM identifiers UMLS ID C0607421 and NCI Concept Code C65482. SMILES: OC(CC(C1CCCCC1)C1CCCCC1)CNC(C)C.